TY - JOUR
T1 - Testicular cancer
AU - Hellerstedt, Beth A.
AU - Pienta, Kenneth J.
PY - 2002
Y1 - 2002
N2 - Testicular cancer remains a major success story in the realm of solid tumors. Although testicular cancer is highly treatable and curable, there are still many young men who succumb to the disease. Over the past year, important data regarding the diagnosis, treatment, and prognosis of testicular cancer have been reported. The significance of genetic and molecular alterations, such as i12p and epidermal growth factor receptor expression, remain at the forefront of research. However surgery and platinum-based chemotherapy are still the main treatment modalities. Attempts to limit chemotherapy and surgery while preserving cure rates are promising. The contribution of long-term platinum retention to the well-documented risk of late toxicity is unknown but provides a specific avenue for research. New tumor markers, such as lactate dehydrogenase isoenzyme-1, may provide a greater risk stratification. Positron emission tomography imaging may reduce the need for surgical resection posttherapy and provide a more comprehensive means of observation.
AB - Testicular cancer remains a major success story in the realm of solid tumors. Although testicular cancer is highly treatable and curable, there are still many young men who succumb to the disease. Over the past year, important data regarding the diagnosis, treatment, and prognosis of testicular cancer have been reported. The significance of genetic and molecular alterations, such as i12p and epidermal growth factor receptor expression, remain at the forefront of research. However surgery and platinum-based chemotherapy are still the main treatment modalities. Attempts to limit chemotherapy and surgery while preserving cure rates are promising. The contribution of long-term platinum retention to the well-documented risk of late toxicity is unknown but provides a specific avenue for research. New tumor markers, such as lactate dehydrogenase isoenzyme-1, may provide a greater risk stratification. Positron emission tomography imaging may reduce the need for surgical resection posttherapy and provide a more comprehensive means of observation.
UR - http://www.scopus.com/inward/record.url?scp=0036254843&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036254843&partnerID=8YFLogxK
U2 - 10.1097/00001622-200205000-00002
DO - 10.1097/00001622-200205000-00002
M3 - Review article
C2 - 11981269
AN - SCOPUS:0036254843
SN - 1040-8746
VL - 14
SP - 260
EP - 264
JO - Current opinion in oncology
JF - Current opinion in oncology
IS - 3
ER -